Osteoarthritis Market Report 2024: Strategies And Recent Developments | Pfizer Inc., Johnson & Johnson, Merck Sharp & Dohme Corp., Abbvie Inc., Bayer AG, Novartis AG, Sanofi SA

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Osteoarthritis Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The osteoarthritis market size has grown rapidly in recent years. It will grow from $6.24 billion in 2023 to $6.87 billion in 2024 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to aging population, obesity epidemic, advances in imaging, pain management.

The osteoarthritis market size is expected to see strong growth in the next few years. It will grow to $9.69 billion in 2028 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to non-pharmacological approaches, disease-modifying osteoarthritis drugs (dmoads), personalized medicine, telehealth and remote monitoring. Major trends in the forecast period include regenerative therapies, wearable devices, artificial intelligence in diagnosis, digital health tools.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=13022&type=smp

Market Segmentation:
The main treatments for osteoarthritis are medication, surgery and therapy. Medication refers to the use of medications or medicine to treat or relieve a certain condition or illness. Osteoarthritis pain can be reduced with the use of medications like nonsteroidal anti-inflammatory drugs (NSAIDs), acetaminophen and opioids. The diagnosis includes imaging and joint fluid analysis. The medication can be administered through the parenteral route, topical route and oral routes for the treatment of knee osteoarthritis, spine osteoarthritis, foot and ankle osteoarthritis, shoulder osteoarthritis and hand osteoarthritis. The end-users are hospitals and medical institutes.

Major Driver - Rising Obesity-Related Disorders Fuel Growth In The Osteoarthritis Market
The increasing obesity-related disorders are expected to boost the growth of the osteoarthritis market going forward. Obesity-related problems refer to a range of health issues that can arise from excessive body fat. It is caused by consuming more calories than the body burns through physical activity and exercise, eating large amounts of processed or fast food and drinking too much alcohol. Obesity can induce osteoarthritis by putting strain on joints, producing inflammation and altering hormones, thus increasing the load on the joints. For instance, according to the World Obesity Atlas 2022, published by the World Obesity Federation, a UK-based non-profit organization, 1 billion people worldwide, including 1 in 7 men and 1 in 5 women, will be living with obesity by 2030 and it will increase to 4 billion people or 51% of the global population, will be living either overweight or obese by 2035. Therefore, the increasing obesity-related disorders are driving the growth of the osteoarthritis market.

Competitive Landscape:
Major players in the osteoarthritis market are Pfizer Inc., Johnson & Johnson, Merck Sharp & Dohme Corp., Abbvie Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca PLC, Abbott Laboratories Incorporation, Eli Lilly and Company, Boehringer Ingelheim, Novo Nordisk A/S, Reckitt Benckiser Group PLC, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Astellas Pharma Inc., Zimmer Biomet Holdings Inc., Eisai Co. Ltd., Horizon Therapeutics PLC, Apotex Inc., Mallinckrodt Pharmaceuticals, Pacira BioSciences Inc., Bioventus Inc., Endo Pharmaceuticals Inc., Assertio Therapeutics Inc., Anika Therapeutics Inc., Abiogen Pharma Spa, Kolon TissueGene Inc., Ampio Pharmaceuticals Inc.

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/osteoarthritis-global-market-report

Top Trend - Innovative Approaches And Advanced Treatments Transform The Osteoarthritis Market
Major companies operating in the osteoarthritis market are focusing on developing new products and advanced treatment drugs, such as small molecule inhibitors, intra-articular injections of hyaluronic acid and single injection viscosupplement, to sustain their market position. For instance, in August 2021, Seikagaku Corporation, a Japan-based pharmaceutical and medical device company, launched HyLink, a single-injection viscosupplement administered intra-particularly for treating knee osteoarthritis. The primary component of this product is crosslinked hyaluronate hydrogel, which was manufactured using Seikagaku's exclusive crosslinking technique. HyLink is anticipated to provide long-lasting relief from symptoms with only a 3ml dosage since the highly viscoelastic hyaluronate hydrogel stays in the knee joint cavity for a considerable time to improve lubrication and reduce pain.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Osteoarthritis Market Characteristics
3. Osteoarthritis Market Trends And Strategies
4. Osteoarthritis Market - Macro Economic Scenario
5. Osteoarthritis Market Size And Growth
…..
27. Osteoarthritis Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries

This release was published on openPR.